VERHALTENSTHERAPIE, published by KARGER, is an authoritative journal in the field of Clinical Psychology and Psychiatry, with its ISSN being 1016-6262 and E-ISSN 1423-0402. This esteemed journal, based in Basel, Switzerland, has been disseminating valuable research insights since its inception in 1991, with a projected convergence up to 2024. Targeting healthcare professionals, researchers, and students, VERHALTENSTHERAPIE focuses on the latest advancements in behavioral therapy, offering a platform for the exchange of rigorous studies and innovative practices. The journal currently holds a Q3 ranking in Clinical Psychology and a Q4 ranking in Psychiatry and Mental Health for 2023, further asserting its role in informing clinical practice and research in these critical areas. Though it does not operate under an open access model, the journal ensures that high-quality research is made available, contributing significantly to both theoretical and practical aspects of mental health. By publishing cutting-edge research, case studies, and reviews, VERHALTENSTHERAPIE aims to foster knowledge and understanding that enriches the fields of psychology and psychiatry.

Multiple Sclerosis and Related Disorders, published by Elsevier Science Ltd, is a leading journal that serves as a vital resource in the field of neurology, particularly focused on multiple sclerosis and its associated conditions. This esteemed journal, which holds a Q1 ranking in Medicine (miscellaneous) and Q2 ranking in both Neurology and Clinical Neurology, delivers high-impact research findings and clinical insights crucial for advancing the understanding and management of multiple sclerosis. With an ISSN of 2211-0348 and an E-ISSN of 2211-0356, it provides valuable content from 2012 to 2024 aimed at researchers, healthcare professionals, and students dedicated to improving patient outcomes and fostering innovative strategies in treatment. Additionally, the journal's presence in the Scopus rankings highlights its relevance and influence in the academic community, ranking 121 out of 400 in Clinical Neurology and 59 out of 192 in Neuroscience. This comprehensive platform encourages the dissemination of cutting-edge knowledge and clinical practices, making it an essential tool for those committed to the field of neurology and related research.

Dusunen Adam-Journal of Psychiatry and Neurological Sciences is a vital resource for scholars and practitioners in the fields of psychiatry and neurology, published by KARE PUBL in Turkey. With an ISSN of 1018-8681 and E-ISSN 1309-5749, this journal has steadily contributed to the academic discourse since its inception, with a dedicated focus on contemporary issues and research findings in psychological and neurological sciences. The journal, which is recognized as Q3 in both the Neurology (clinical) and Psychiatry and Mental Health categories, currently ranks #413 out of 567 in Psychiatry and Mental Health and #298 out of 400 in clinical Neurology according to Scopus. Its commitment to advancing knowledge in these critical areas makes it a significant platform for researchers, professionals, and students alike, fostering a deeper understanding of mental health and neurological disorders that are increasingly relevant in our society. As Dusunen Adam continues to evolve through its convergence years from 2011 to 2024, it remains dedicated to enhancing the quality of life through research and evidence-based practices.

Eurasian Journal of Medicine, published by Atatürk University, stands as a vital resource in the field of medicine, particularly within the context of Eurasian healthcare advancements. Established as an Open Access journal since 1969, it is committed to distributing high-quality research widely, ensuring that vital findings are accessible to researchers, practitioners, and medical students alike. With an impact factor indicative of its relevance, the journal is currently ranked #251 out of 636 in the "General Medicine" category within Scopus, placing it in the 60th percentile and holding a Q3 quartile classification for 2023. Covering a diverse range of topics in medicine from 2012 to 2024, the journal publishes novel research, reviews, and clinical studies that contribute to the understanding and practice of medicine in transition. Located in Erzurum, Turkey, the Eurasian Journal of Medicine aspires to foster dialogue and innovation in the medical community worldwide.

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE is a pivotal journal in the fields of neurology, psychiatry, and related medical disciplines, published by GEORG THIEME VERLAG KG in Germany. With a history dating back to 1955, this journal has evolved to address the dynamic nature of neurological and psychiatric research, offering valuable insights and advancements in the field. Despite holding a Q4 category status in various medical domains according to the 2023 quartiles, the journal continues to foster academic discussion and engagement among researchers and clinicians alike. It serves as a vital platform for disseminating knowledge through original research articles, reviews, and clinical studies, making it an essential resource for professionals and students aiming to stay abreast of the latest developments in mental health and neurological science. Although the journal currently does not offer open access options, its contribution to the academic community is significant, helping to illuminate the intricate relationships between neurological disorders and psychiatric conditions.

Journal of Psychopathology, published by PACINI EDITORE, is a pivotal academic resource in the realms of clinical psychology and psychiatry. With an ISSN of 1592-1107 for print and 2499-6904 for electronic formats, this journal has been a significant platform for scholarly discourse since its inception in 2001, continuing through to 2024. Situated in Pisa, Italy, it is recognized for its rigorous academic standards, as evidenced by its Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health categories as of 2023. The journal focuses on publishing high-quality research articles, reviews, and case studies that contribute to a comprehensive understanding of psychopathological issues. Although not open access, the journal promotes accessibility through various institutional subscriptions, ensuring wide dissemination of valuable insights. With significant Scopus rankings—177 out of 311 in Clinical Psychology and 360 out of 567 in Psychiatry and Mental Health—the journal is essential for researchers, practitioners, and students dedicated to advancing knowledge and practices in mental health.

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.

Progress in Neurology and Psychiatry is a pivotal journal published by John Wiley & Sons Ltd, dedicated to advancing the fields of neurology and psychiatry. With a robust history dating back to its establishment, this esteemed journal holds a consistent Q3 ranking in 2023 across several categories including Neurology, Clinical Neurology, Psychiatry, and Mental Health, signifying its significant contribution to the scientific community. This journal serves as a vital source of knowledge and insight, publishing original research, reviews, and case studies that explore the intricacies of neurological and psychiatric disorders. Although it does not offer open access, the journal remains accessible to a wide audience through institutional subscriptions. By fostering a platform for scholarly discourse, Progress in Neurology and Psychiatry aims to bridge the gap between research and practice, ultimately enhancing the quality of care for individuals with neurological and psychiatric conditions. Researchers, clinicians, and students are encouraged to engage with the journal's comprehensive content to stay informed of the latest developments and emerging trends in these critical fields of medicine.

Case Reports in Neurological Medicine is a premier open-access journal published by HINDAWI LTD, dedicated to advancing knowledge in the field of neurology through the dissemination of detailed case reports. Established in 2011, this journal provides a platform for researchers, clinicians, and students alike to share unique experiences and findings that contribute to the evolving landscape of neurological medicine. With an ISSN of 2090-6668 and an E-ISSN of 2090-6676, the journal promotes high-quality research that underscores the significance of individual cases in understanding complex neurological disorders. By ensuring open access to its content, Case Reports in Neurological Medicine enhances the visibility and impact of crucial clinical insights, fostering collaboration and innovation among professionals in the field. This commitment to accessibility and scholarly excellence makes it an invaluable resource for anyone keen to explore the intricacies of neurological medicine.

NORDIC JOURNAL OF PSYCHIATRY is a pivotal publication in the field of psychiatry and mental health, dedicated to advancing knowledge and fostering dialogue among researchers, clinicians, and students. Published by Taylor & Francis Ltd, this esteemed journal, with an ISSN of 0803-9488 and E-ISSN 1502-4725, serves as a platform for innovative research and critical reviews that address crucial mental health issues affecting Nordic populations and beyond. Its impact is underscored by a notable Q2 ranking in the Psychiatry and Mental Health category for 2023, along with a respectable position within the Scopus ranking at #268 out of 567. The journal has been a reliable source of scientific inquiry since its inception in 1947, and it aims to facilitate significant advancements in the understanding and treatment of psychiatric disorders. By providing access to high-quality research without open access options, NORDIC JOURNAL OF PSYCHIATRY remains a must-read for those dedicated to progressing mental health science in a global context.